Recently, Yamaguchi et al. demonstrated that the CCL5–CCR3 interaction contributed to tumor progression suggesting that this axis may be an important target to improve the prognosis of breast cancer patients [63]. This evidence concerns the gene CCR3 and breast carcinoma.